Emami, a leading FMCG major, is set to enter the nutraceuticals segment with a scientifically researched and clinically validated product range. The move is part of its strategy to build “new engines of growth” in high-margin, high-potential categories.

Vice Chairman and MD Harsha V Agarwal stated that the company is clearing regulatory hurdles to facilitate entry into newer markets for its healthcare business, aiming for a sharper and future-proof portfolio within three to five years. The diversification will also focus on allied segments like health foods, nutrition, pet care, and aloe verabased fruit juices. 

Nutraceuticals and FMCG are converging as health and wellness become central to daily consumption. The company intends to introduce clean label, eco-conscious offerings for urban consumers and affordable branded options for rural markets. With flagship brands like Boro Plus, Navratna, Fair and Handsome, and Zandu, Emami sees strong potential in underpenetrated markets. Currently, 45 percent of its revenues stem from high-growth areas such as modern trade, e-commerce, institutional channels, strategic subsidiaries, and international business, providing both scale and resilience to its expansion drive.